Paris Payton, DPM
Foot & Ankle Surgery · Roswell, GANPI 1487174561
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Stryker at 36.2% of the total. 2025 is the largest year on record at $3,553, 2.1 times the $1,653 reported in 2019.
Across 67 payments — averaging $105.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Rock Medical Orthopedics, Inc.$1K
- Treace Medical Concepts, Inc.$848
- Medline Industries LP$830
- Paragon 28, Inc.$739
- Integra Lifesciences Corporation$314
- plus $699 from 10 others
What the payments were for
- Travel & lodging$3,25346%
- Food & beverage$2,66938%
- Education$1,13216%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $2,552 |
| Rock Medical Orthopedics, Inc. | 2 | $1,073 |
| Treace Medical Concepts, Inc. | 10 | $848 |
| Medline Industries LP | 6 | $830 |
| Paragon 28, Inc. | 2 | $739 |
| Integra Lifesciences Corporation | 6 | $314 |
| Smith+Nephew | 4 | $230 |
| GRT US Holding, Inc. | 4 | $189 |
| Medtronic | 1 | $65 |
| Organogenesis Inc. | 2 | $43 |
| Mimedx Group, Inc. | 1 | $38 |
| Boston Scientific | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 1 | $29 |
| Dynasplint Systems Inc. | 1 | $27 |
| KCI USA, Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 2 LAPIFUSE$1,292
- Product Portfolio$739
- Lapiplasty System$571
- ORTHOLOC 3DI$341
- INFINITY ADAPTIS$152
- PROSTEP MICA$138
- VERSAJET II$125
- Qutenza$125
- OMNIGRAFT$110
- PRIMATRIX$110
- MEDIHONEY$110
- TCC-EZ$110
- AMNIOEXCEL$110
How this compares
$7,054 in reported general payments places this provider in the 75th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcipotriene-BetamethasoneCalcipotriene/Betamethasone | 11 | $11,822 |
| Clobetasol Propionate | 27 | $7,740 |
| Ammonium Lactate | 208 | $4,076 |
| Halobetasol Propionate | 19 | $2,682 |
| Diclofenac Sodium | 79 | $1,990 |
| Clotrimazole | 80 | $959 |
| Ketoconazole | 15 | $255 |
| Methylprednisolone | 11 | $57 |
| Cephalexin | 13 | $34 |
| Meloxicam | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Roswell
- Richard KaufmanRoswell$25K
- Lance SilvermanRoswell$20K
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.